Thompson Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11K Hold
82
﹤0.01% 480
2026
Q1
$491 Hold
82
﹤0.01% 484
2025
Q4
$588 Hold
82
﹤0.01% 506
2025
Q3
$876 Hold
82
﹤0.01% 492
2025
Q2
$794 Hold
82
﹤0.01% 461
2025
Q1
$1.22K Hold
82
﹤0.01% 447
2024
Q4
$1.22K Hold
82
﹤0.01% 459
2024
Q3
$1.57K Hold
82
﹤0.01% 449
2024
Q2
$1.7K Hold
82
﹤0.01% 450
2024
Q1
$1.54K Hold
82
﹤0.01% 461
2023
Q4
$1.18K Hold
82
﹤0.01% 393
2023
Q3
$1.42K Hold
82
﹤0.01% 379
2023
Q2
$1.71K Hold
82
﹤0.01% 380
2023
Q1
$1.93K Buy
+82
New +$2.2K ﹤0.01% 372

Other funds holding OGN

Thompson Investment Management's OGN Position: Q2 2026 in Review

Thompson Investment Management held its Organon & Co (OGN) position steady in Q2 2026 at 82 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

Thompson Investment Management first reported a position in OGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.93K in Q1 2023. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Thompson Investment Management held 82 shares of Organon & Co worth $1.11K as of Q2 2026.
  • Thompson Investment Management left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Thompson Investment Management's portfolio in Q2 2026, its #480 holding.
  • Thompson Investment Management first reported a position in Organon & Co in Q1 2023 and has held it in 14 quarters since.
  • Thompson Investment Management's Organon & Co position peaked at $1.93K in Q1 2023.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.